Search

Search

Filter
501 - 510 of 1306 results

Results for

mother and young daughter on a beach near a wind farm

Public Health Benefits per kWh of Energy Efficiency and Renewable Energy in the United States: A Technical Report

Publication
These values help state and local policymakers estimate the monetized public health benefits of investments in energy efficiency and renewable energy (EE/RE).
The Work of John Mayne: Using Evaluative Information Sensibly to Bridge the Gaps Between Evaluation and Monitoring

The Work of John Mayne: Using Evaluative Information Sensibly to Bridge the Gaps Between Evaluation and Monitoring

Publication
Sebastian Lemire co-authored three articles on John Mayne’s evaluation work in a special edition of The Canadian Journal of Program Evaluation.
Massachusetts Clean Energy and Climate Plan for 2020

Massachusetts Clean Energy and Climate Plan for 2020

Publication
Updating EPA’s Greenhouse Gas Reporting Program Annual Data Highlights

Updating EPA’s Greenhouse Gas Reporting Program Annual Data Highlights

Project
The Environmental Protection Agency (EPA) has been collecting greenhouse gas emissions data through the Greenhouse Gas Reporting Program (GHGRP) from approximately 8,000 emitters—including power plants, oil and gas producers, and manufacturers—since 2010…
Section 811 Project Rental Assistance Program Phase II Evaluation

Section 811 Project Rental Assistance Program Phase II Evaluation

Publication
Evaluating REL Pacific’s Secondary Writing Toolkit

Evaluating REL Pacific’s Secondary Writing Toolkit

Project
Literacy—including writing—is closely tied to student success throughout K–12 education, impacting high school graduation and, ultimately, income after graduation. But students across the United States perform poorly on assessments of writing and,…
Evaluating the Cell and Gene Therapy Access Model

Evaluating the Cell and Gene Therapy Access Model

Project
The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.